IHS Chemical Week

Regions :: India/Pakistan

Shasun completes US and Mexican regulatory inspections of Cuddalore API plant

11:08 AM MDT | July 8, 2014 | Natasha Alperowicz

Shasun Pharmaceuticals (Chennai, India) said today that it has successfully completed both US FDA and Mexican Cofepris regulatory inspections at its active pharma ingredients facility at Cuddalore, Tamil Nadu State, India. The FDA audit was held in the second week of June and the Cofepris audit by APIF during the last week of June. The FDA inspectors conclude that the facility, systems, and practices comply with FDA requirements, and, when done the inspection, APIF concluded that Shasun’s compliance with cGMP are fully met and that...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa